Distinguished in Neurofibromatosis Type 1 (NF1)

Dr. Kee D. Kim

Neurosurgery
Regents Of The Univ Of Ca
2315 Stockton Blvd, 
Sacramento, CA 
Offers Telehealth
Distinguished in Neurofibromatosis Type 1 (NF1)
Regents Of The Univ Of Ca
2315 Stockton Blvd, 
Sacramento, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Kee Kim is a Neurosurgery provider in Sacramento, California. Dr. Kim is rated as a Distinguished provider by MediFind in the treatment of Neurofibromatosis Type 1 (NF1). His top areas of expertise are Invertebral Disc Disease, Cervical Spondylosis, Cervical Myelopathy, Laminectomy, and Cervical Disc Surgery.

His clinical research consists of co-authoring 108 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Neurosurgery
Licenses
Neurological Surgery in CA
Hospital Affiliations
Sierra Nevada Memorial Hospital
Mark Twain Medical Center
Oroville Hospital
University Of California Davis Medical Center
Adventist Health And Rideout
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 2 Less Insurance Carriers -

Locations

REGENTS OF THE UNIV OF CA
2315 Stockton Blvd, Sacramento, CA 95817
Other Locations
REGENTS OF THE UNIV OF CA
3301 C St, Suite 1500, Sacramento, CA 95816
REGENTS OF THE UNIV OF CA
4860 Y St, Sacramento, CA 95817

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Prospective, Randomized, Multi-Center, Open-Label Pilot Study of Infuse® Bone Graft With Mastergraft® Strip and Posterior Fixation for Posterolateral Fusion (PLF) Treatment of Multi-Level Degenerative Lumbosacral Spinal Conditions
A Prospective, Randomized, Multi-Center, Open-Label Pilot Study of Infuse® Bone Graft With Mastergraft® Strip and Posterior Fixation for Posterolateral Fusion (PLF) Treatment of Multi-Level Degenerative Lumbosacral Spinal Conditions
Enrollment Status: Active_not_recruiting
Publish Date: June 08, 2025
Intervention Type: Device
Study Phase: Not Applicable
Randomized, Controlled, Single-blind Study of Probable Benefit of the Neuro-Spinal Scaffold™ for Safety and Neurologic Recovery in Subjects With Complete Thoracic AIS A Spinal Cord Injury as Compared to Standard of Care
Randomized, Controlled, Single-blind Study of Probable Benefit of the Neuro-Spinal Scaffold™ for Safety and Neurologic Recovery in Subjects With Complete Thoracic AIS A Spinal Cord Injury as Compared to Standard of Care
Enrollment Status: Terminated
Publish Date: January 17, 2024
Intervention Type: Device
Study Phase: Not Applicable
The INSPIRE Study: InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold(TM) for Safety and Neurologic Recovery in Subjects With Complete Thoracic AIS A Spinal Cord Injury
The INSPIRE Study: InVivo Study of Probable Benefit of the Neuro-Spinal Scaffold(TM) for Safety and Neurologic Recovery in Subjects With Complete Thoracic AIS A Spinal Cord Injury
Enrollment Status: Terminated
Publish Date: January 17, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of a Single Injection of Rexlemestrocel-L Alone or Combined With Hyaluronic Acid (HA) in Subjects With Chronic Low Back Pain
A Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of a Single Injection of Rexlemestrocel-L Alone or Combined With Hyaluronic Acid (HA) in Subjects With Chronic Low Back Pain
Enrollment Status: Completed
Publish Date: October 19, 2022
Intervention Type: Drug
Study Drugs: Rexlemestrocel-L, Rexlemestrocel-L+Hyaluronic Acid
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Controlled Study of EXPAREL for Postsurgical Pain Management in Subjects Undergoing Open Lumbar Spinal Fusion Surgery
A Multicenter, Randomized, Double-Blind, Controlled Study of EXPAREL for Postsurgical Pain Management in Subjects Undergoing Open Lumbar Spinal Fusion Surgery
Enrollment Status: Terminated
Publish Date: October 13, 2021
Intervention Type: Drug
Study Phase: Phase 4
View 4 Less Clinical Trials

108 Total Publications

The Cannabinoid Pharmacology of Bone Healing: Developments in Fusion Medicine.
The Cannabinoid Pharmacology of Bone Healing: Developments in Fusion Medicine.
Journal: Biomedicines
Published: June 02, 2025
Similar Doctors
Experienced in Neurofibromatosis Type 1 (NF1)
Dr. James W. Silverthorn
Neurosurgery
Experienced in Neurofibromatosis Type 1 (NF1)
Dr. James W. Silverthorn
Neurosurgery

Sacramento Medical Center

2025 Morse Ave, 3rd Floor 3-D, 
Sacramento, CA 
 (4.6 miles away)
916-973-5490
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

James Silverthorn is a Neurosurgery provider in Sacramento, California. Dr. Silverthorn is rated as an Experienced provider by MediFind in the treatment of Neurofibromatosis Type 1 (NF1). His top areas of expertise are Subdural Hematoma, Hydrocephalus, Chronic Subdural Hematoma, Awake Craniotomy, and Extracranial-Intracranial Bypass Surgery. Dr. Silverthorn is currently accepting new patients.

Experienced in Neurofibromatosis Type 1 (NF1)
Dr. Sean A. Mcnatt
Neurosurgery | Pediatrics
Experienced in Neurofibromatosis Type 1 (NF1)
Dr. Sean A. Mcnatt
Neurosurgery | Pediatrics

Permanente Medical Group Inc

1600 Eureka Rd, 
Roseville, CA 
 (17.3 miles away)
916-784-4000
Languages Spoken:
English
See accepted insurances

Sean Mcnatt is a Neurosurgery specialist and a Pediatrics provider in Roseville, California. Dr. Mcnatt is rated as an Advanced provider by MediFind in the treatment of Neurofibromatosis Type 1 (NF1). His top areas of expertise are Cerebellum Agenesis Hydrocephaly, Syringomyelia, Syringobulbia, Craniectomy, and Awake Craniotomy.

Advanced in Neurofibromatosis Type 1 (NF1)
Dr. Julius Ebinu
Neurosurgery
Advanced in Neurofibromatosis Type 1 (NF1)
Dr. Julius Ebinu
Neurosurgery
2315 Stockton Blvd, 
Sacramento, CA 
 (0.1 miles away)
866-830-9125
Languages Spoken:
English

Julius Ebinu is a Neurosurgery provider in Sacramento, California. Dr. Ebinu is rated as an Advanced provider by MediFind in the treatment of Neurofibromatosis Type 1 (NF1). His top areas of expertise are Cervical Myelopathy, Subdural Hematoma, Spinal Stenosis, Laminectomy, and Bone Graft.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kim's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 41 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile